Jolanda Howe, Senior Vice President and Global Controller at Mirum Pharmaceuticals, Inc. (), sold shares of the company’s common stock on September 2, 2026. Ms. Howe disposed of 658 shares at a price of $100 per share, totaling $65,800. Following
Salvatore Privitera, Chief Technical Officer at AtriCure, Inc. (), sold shares of the company’s common stock totaling $407,557 on September 2, 2026. Mr. Privitera disposed of 7,763 shares at a price of $52.50 per share. These shares were sold pursuant
Chris J Kneppers, a director at BLUE BIOFUELS, INC. (), sold a total of $91,000 worth of common stock in three separate transactions earlier this month. The sales occurred between September 1 and September 3, 2026. Mr. Kneppers disposed of 1,000,000
Yves Le Pendeven, Chief Financial Officer of Funko, Inc. (), recently sold a total of $281,946 worth of company stock across several transactions. The sales occurred between August 28, 2026, and September 1, 2026, with prices ranging from $6.5067 to $7.0154 per share.
Repass Wolfe, Chief Financial Officer of Fold Holdings, Inc. (), sold shares of the company’s common stock on September 2, 2026, totaling $613. The sales were made at a price of $0.457 per share. The stock currently trades at $0.49,
Mark D. Walker, Chairman and CEO of Direct Digital Holdings, Inc. (), recently sold shares of the company’s Class A Common Stock totaling $4,315. The sales occurred over two days in early September, with prices for
Scott L. Burrows, Chief Financial Officer of Spyre Therapeutics, Inc. (), sold common stock valued at approximately $2.28 million across multiple transactions on September 1 and September 2, 2026. Burrows also acquired shares through the exercise of stock options during
Thomas J. Dickman, Chief Technology Officer at Fold Holdings, Inc. (), sold 6 shares of the company’s common stock on September 2, 2026. The shares were sold at a price of $0.457 each, totaling $2. This transaction was executed to
John Thompson, a director and 10% owner of Rubrik, Inc. (), sold a total of 13,500 shares of the company’s Class A common stock on September 1, 2026. The transactions amounted to approximately $1,201,946. The sale comes as RBRK trades
Srikanth Radhakrishnan, Chief Science & Techn. Officer at Pulmonx Corp (), sold 14,245 shares of common stock on September 1, 2026, for a total value of $32,192. The shares were sold at a price of $2.26 per share. The transactions included four
